Photocure ASA

Report Publication Announcement • Dec 13, 2017

Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo

Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo

Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that

the company will present at the DNB Nordic Healthcare Conference on 14th of

December 2017 in Oslo, Norway. Presenter will be Ambaw Bellete, President,

Photocure Inc. and Head, US Cancer Commercial Operations. The slides presented

will be available on Photocure's website (www.photocure.com) in the investor

relations section.

Company contact:

Erik Dahl, Chief Financial Officer

Tel: +47 450 55 000

Email: ed@photocure.no

About Photocure

Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company

focusing on urology. Based on its unique proprietary Photocure Technology®

platform, Photocure is committed to developing and commercializing highly

selective and minimally invasive solutions to improve health outcomes for

patients worldwide. The company is listed on the Oslo Stock Exchange (OSE: PHO).

More information about Photocure is available at www.photocure.com,

www.hexvix.com, www.cysview.com.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.